Literature DB >> 10650668

[Budesonide and inflammatory bowel disease].

F Gomollón1, J Hinojosa, P Nos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10650668

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN： 0210-5705            Impact factor:   2.102


× No keyword cloud information.
  4 in total

1.  Budesonide ameliorates early portal hypertension in the rat: possible antiexudative splanchnic action.

Authors:  M Vega De Céniga; F Valdés; M A Aller; M P Nava; T Chivato; J Arias
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

Review 2.  Oral budesonide for induction of remission in ulcerative colitis.

Authors:  Mary E Sherlock; John K MacDonald; Anne Marie Griffiths; A Hillary Steinhart; Cynthia H Seow
Journal:  Cochrane Database Syst Rev       Date:  2015-10-26

Review 3.  Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis.

Authors:  Marisa Iborra; Diego Alvarez-Sotomayor; Pilar Nos
Journal:  Clin Exp Gastroenterol       Date:  2014-02-05

4.  Mesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/drugs in colon.

Authors:  Daniel Ferri; Pablo Gaviña; Margarita Parra; Ana M Costero; Jamal El Haskouri; Pedro Amorós; Virginia Merino; Adrián H Teruel; Félix Sancenón; Ramón Martínez-Máñez
Journal:  R Soc Open Sci       Date:  2018-08-15       Impact factor: 2.963
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.